BAP1-TPDS is characterized by increased risk of solid tumors, including mesothelioma, cutaneous and uveal melanoma, renal cell carcinoma, and BAP1-inactivated melanocytic tumors [2]. This evidence concerns the gene BAP1 and renal cell carcinoma.